Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phototoxicity Test of BAY987517 in Healthy Volunteers
NCT02962856Phase 1Completed
- Sponsor
- Bayer
- Start
- Nov 2016
- Primary completion
- Nov 2016
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BAY987517 in sunburn, sponsored by Bayer. Primary endpoint: Intensity of skin reactions at 48 hours. Started Nov 2016; status: completed.
02
Drugs
BAY987517
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT02962856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962856.